Financials
- Market Capitalization 1.53 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-30.04
売上高対価格比率
14.91
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2146 | VIR Vir Biotechnology, Inc. - Common Stock | 9.47 USD | -0.21% | -8.41% | +9.86% | +58.36% | 1.60 B USD | ||
| 2147 | ABSI Absci Corporation - Common Stock | 10.17 USD | -0.59% | -6.61% | +39.51% | +286.69% | 1.59 B USD | ||
| 2172 | AVBP ArriVent BioPharma, Inc. - Common Stock | 32.83 USD | +0.89% | -4.51% | +7.99% | +50.73% | 1.53 B USD | ||
| 2210 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 19.53 USD | +0.05% | +1.72% | +1.35% | +104.29% | 1.44 B USD |